anti-HER2 molecule AIP-303
Term · Oncology and biomedicine · MLC-T-ONC-010749
A molecule targeting the tumor-associated antigen (TAA) epidermal growth factor receptor 2 (HER2, EGFR2, ERBB2), with potential antineoplastic activity. Upon administration, the anti-HER2 molecule AIP-303 targets and binds to HER2-expressing cells. This may inhibit HER2-mediated signaling and inhibit growth in HER2-overexpressing tumor cells. HER2, a tyrosine kinase, is overexpressed on the cell surfaces of various tumor cell types.
| Identifier | MLC-T-ONC-010749 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010749",
"term": "anti-HER2 molecule AIP-303",
"field": "Oncology and biomedicine",
"definition": "A molecule targeting the tumor-associated antigen (TAA) epidermal growth factor receptor 2 (HER2, EGFR2, ERBB2), with potential antineoplastic activity. Upon administration, the anti-HER2 molecule AIP-303 targets and binds to HER2-expressing cells. This may inhibit HER2-mediated signaling and inhibit growth in HER2-overexpressing tumor cells. HER2, a tyrosine kinase, is overexpressed on the cell surfaces of various tumor cell types.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-her2-molecule-aip-303/"
}
Record 1,857 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.